|
|
The 26th Annual Miami Breast Cancer Conference (MBCC) provides practicing surgical and medical oncologists with a multidisciplinary approach to breast cancer management, with incorporation of molecular biologic translation from the laboratory to the clinic.
The primary purpose of this conference continues to be, “what can you learn that you can use Monday morning and what can you look forward to on Friday?” |
| |
|
|
Watch the video presentations of all lectures
|
|
Read about current events and news covered by MBCC News |
| |
|
2008 Program Highlights
- Benign Breast Disease
- Chemoprevention
- Management of Uncommon Carcinomas
- Oncoplastic Surgery
- Systemic Therapy
- Stem Cells: The Birth of Tumor Cells; Apoptosis: The Death of Tumor Cells; Do Cancers Arise From Stem Cells?
- Apoptosis
- Predictors of Drug Response
- Heterogeneity of Breast Cancer
- Biology of Metastatic Disease
- Management of Organ-Specific Metastases
- Optimizing Therapy With Endocrine or Targeted Agents
- Preoperative Therapy and Surveillance
|
| |
Don't miss the next meeting!
2009 Miami Breast Cancer Conference
March 4-7, 2009
Fontainebleau Resort and Hotel
Miami, FL |
| |
|
|
Thank you to our 2008 Educational Partners:
Genentech
BioOncology
GlaxoSmithKline
Novartis Oncology
Pfizer Oncology
Major Contributors:
Bristol-Myers Squibb
Lilly Oncology
sanofi-aventis U.S.
Supporters:
Abraxis BioScience
AstraZeneca
|
| |
|
|
